Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pancreatic cancer biomarkers and uses thereof

Pancreatic cancer biomarkers and uses thereof

US Patent 11041866 · Granted Jun 22, 2021

Estimated economic value: $5,224,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Lung cancer biomarkers and uses thereof2022
Cardiovascular risk event prediction and uses thereof2020
Lung cancer biomarkers and uses thereof2019
Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH)2019
Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH)2018
Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH)2017
Chronic obstructive pulmonary disease (COPD) biomarkers and uses thereof2016
Chronic obstructive pulmonary disease (COPD) biomarkers and uses thereof2016
Chronic obstructive pulmonary disease (COPD) biomarkers and uses thereof2015
Chronic obstructive pulmonary disease (COPD) biomarkers and uses thereof2015
Flow-through optical assay devices providing laminar flow of fluid samples, and 2006
Device for mass transport assisted optical assays2005